Clinical trial
Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal…
NCT00026234 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026234 |
|---|---|
| Title | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver |
| Official title | A Phase II Trial Evaluating Multiple Metastasectomy Combined With Hepatic Artery Infusion Of Floxuridine (FUDR) And Dexamethasone (DXM), Alternating With Systemic Oxaliplatin (OXAL) And Capecitabine (CAPCIT) For Colorectal Carcinoma Metastatic To The Liver |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | NSABP Foundation Inc |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer |
| Intervention type | Drug |
| Interventions | floxuridine, dexamethasone, oxaliplatin, capecitabine |
| Enrollment | 75 |
| Start date | Feb 1, 2002 |
| Primary completion | Jan 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: